Submitted by Anonymous (not verified) on 19 February 2025 - 14:50
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 9, Status: Authorised
Source: